BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM. Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol 2015; 21(28): 8678-8686 [PMID: 26229410 DOI: 10.3748/wjg.v21.i28.8678]
URL: https://www.wjgnet.com/1007-9327/full/v21/i28/8678.htm
Number Citing Articles
1
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Adenocarcinoma ductal de páncreas. Experiencia de 11 años en un centro de tercer nivelRevista de Gastroenterología de México 2021; 86(2): 118 doi: 10.1016/j.rgmx.2020.04.004
2
Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. BRCA in Gastrointestinal Cancers: Current Treatments and Future PerspectivesCancers 2020; 12(11): 3346 doi: 10.3390/cancers12113346
3
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
4
Penpa Dorjee, Zi-Wen Long. A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancerCancer Biology & Therapy 2018; 19(6): 497 doi: 10.1080/15384047.2018.1433503
5
Divyanshoo R. Kohli, Ken Robert Smith, Jathine Wong, Zhe Yu, Kenneth Boucher, Douglas O. Faigel, Rahul Pannala, Randall W. Burt, Karen Curtin, N. Jewel Samadder. Familial pancreatic cancer risk: a population-based study in UtahJournal of Gastroenterology 2019; 54(12): 1106 doi: 10.1007/s00535-019-01597-3
6
Wataru Gonoi, Takana Yamakawa Hayashi, Hidemi Okuma, Masaaki Akahane, Yousuke Nakai, Suguru Mizuno, Ryosuke Tateishi, Hiroyuki Isayama, Kazuhiko Koike, Kuni Ohtomo. Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case–cohort studyEuropean Radiology 2017; 27(12): 4941 doi: 10.1007/s00330-017-4895-8
7
Ji Kon Ryu. The Early Detection of Pancreatic Cancer: Whom and How?Korean Journal of Pancreas and Biliary Tract 2015; 20(4): 198 doi: 10.15279/kpba.2015.20.4.198
8
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening programHereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
9
Thomas Hank, Oliver Strobel. Conversion Surgery for Advanced Pancreatic CancerJournal of Clinical Medicine 2019; 8(11): 1945 doi: 10.3390/jcm8111945
10
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic CancerInternational Journal of Molecular Sciences 2019; 20(3): 561 doi: 10.3390/ijms20030561
11
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care2019; : 1 doi: 10.1007/978-3-319-74698-2_180-1
12
Kasper A. Overbeek, Djuna L. Cahen, Marco J. Bruno. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individualsFamilial Cancer 2024;  doi: 10.1007/s10689-024-00380-5
13
Hideyuki Fukui, Hiromitsu Onishi, Atsushi Nakamoto, Takahiro Tsuboyama, Takashi Ota, Keigo Yano, Yukihiro Enchi, Daisaku Yamada, Yu Takeda, Shogo Kobayashi, Yasunari Fukuda, Hidetoshi Eguchi, Takahiro Matsui, Mitsuaki Tatsumi, Noriyuki Tomiyama. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancerEuropean Journal of Radiology 2022; 156: 110522 doi: 10.1016/j.ejrad.2022.110522
14
Tianle Zou, Dan Shi, Weiwei Wang, Guoyong Chen, Xianbin Zhang, Yu Tian, Peng Gong, Jinghua Pan. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic CancerMediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/5565054
15
Priyanka Jha, Benjamin M. Yeh, Ronald Zagoria, Eric Collisson, Zhen J. Wang. The Role of MR Imaging in Pancreatic CancerMagnetic Resonance Imaging Clinics of North America 2018; 26(3): 363 doi: 10.1016/j.mric.2018.03.004
16
R. S. O’Neill, B. Meiser, S. Emmanuel, D. B. Williams, A. Stoita. Long-term positive psychological outcomes in an Australian pancreatic cancer screening programFamilial Cancer 2020; 19(1): 23 doi: 10.1007/s10689-019-00147-3
17
Federico Salom, Frédéric Prat. Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancerWorld Journal of Gastrointestinal Endoscopy 2022; 14(1): 35-48 doi: 10.4253/wjge.v14.i1.35
18
Sung Bum Kim. Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset DiabetesThe Korean Journal of Gastroenterology 2018; 72(3): 159 doi: 10.4166/kjg.2018.72.3.159
19
Julia Benzel, Volker Fendrich. Familial Pancreatic CancerOncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
20
Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey Risch, James J. Farrell. Current Approaches to Pancreatic Cancer ScreeningThe American Journal of Pathology 2019; 189(1): 22 doi: 10.1016/j.ajpath.2018.09.013
21
Jingjing Lyu, Xin Guan, Yuhan Zhou, Huan Guo, Shanshan Cheng, Chaolong Wang. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng‐Tongji cohortJournal of Evidence-Based Medicine 2023; 16(1): 39 doi: 10.1111/jebm.12516
22
Joan Llach, Paula Aguilera, Ariadna Sánchez, Angels Ginès, Glòria Fernández-Esparrach, Guillem Soy, Oriol Sendino, Eva Vaquero, Sabela Carballal, Fabio Ausania, Juan Ramón Ayuso, Anna Darnell, María Pellisé, Sergi Castellví-Bel, Susana Puig, Francesc Balaguer, Leticia Moreira. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2ACancers 2023; 15(6): 1690 doi: 10.3390/cancers15061690
23
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Pancreatic cancerThe Lancet 2020; 395(10242): 2008 doi: 10.1016/S0140-6736(20)30974-0
24
Elisabeth King, Bita Nehoray. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk FamiliesClinical Journal of Oncology Nursing 2019; 23(6): 579 doi: 10.1188/19.CJON.579-582
25
Chris M. Lindquist, Frank H. Miller, Nancy A. Hammond, Paul Nikolaidis. Pancreatic cancer screeningAbdominal Radiology 2018; 43(2): 264 doi: 10.1007/s00261-017-1308-z
26
Juan E. Corral, Ananya Das, Marco J. Bruno, Michael B. Wallace. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk IndividualsPancreas 2019; 48(4): 526 doi: 10.1097/MPA.0000000000001268
27
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societiesClinical and Translational Oncology 2017; 19(7): 834 doi: 10.1007/s12094-016-1609-7
28
Amr F. Mourad, Mona M. Sayed, Hussein Fakhry. Is magnetic resonance diffusion-weighted imaging superior in the diagnosis of pancreatic adenocarcinoma and does it have a prognostic value?The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4): 908 doi: 10.1016/j.ejrnm.2018.06.001
29
Kai Jia, Steven Kundrot, Matvey B. Palchuk, Jeff Warnick, Kathryn Haapala, Irving D. Kaplan, Martin Rinard, Limor Appelbaum. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical dataeBioMedicine 2023; 98: 104888 doi: 10.1016/j.ebiom.2023.104888
30
Elena M. Stoffel, Shannon E. McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M. Petersen, Diane M. Simeone, Matthew Yurgelun, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical OpinionJournal of Clinical Oncology 2019; 37(2): 153 doi: 10.1200/JCO.18.01489
31
Louis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, Vinciane Rebours, Jérôme Cros, Nadem Soufir, Pascal Hammel. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriersEndocrine-Related Cancer 2016; 23(10): T57 doi: 10.1530/ERC-16-0269
32
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, Shakiba Azami, Seyyedeh Helya Mirnourbakhsh, Majid Khazaei, Gordon A. Ferns, Majid Rajabian, Amir Avan. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancerLife Sciences 2021; 270: 119118 doi: 10.1016/j.lfs.2021.119118
33
Fundamentals of Cancer Detection, Treatment, and Prevention2022; : 341 doi: 10.1002/9783527838561.ch15
34
M.-P. Vullierme, M. Lagadec. Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?Journal de Radiologie Diagnostique et Interventionnelle 2016; 97(5): 509 doi: 10.1016/j.jradio.2016.10.003
35
Jérôme Schwingel, Miriam Decker, Lisa Schneider, Carsten Johannes Stürmer, Manfred P. Lutz. Early Detection of Pancreatic CancerOncology Research and Treatment 2023; 46(6): 259 doi: 10.1159/000530790
36
Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Szymon Grochans, Anna M. Cybulska, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Piotr Ratajczak, Karolina Kamecka, Michał Marczak, Remigiusz Kozłowski. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk PopulationsCancers 2023; 15(14): 3634 doi: 10.3390/cancers15143634
37
Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent SurgeryCancer Control 2023; 30: 107327482311547 doi: 10.1177/10732748231154711
38
I.J.M. Levink, D.C.F. Klatte, R.G. Hanna-Sawires, G.C.M. Vreeker, I.S. Ibrahim, Y.E.M. van der Burgt, K.A. Overbeek, B.D.M. Koopmann, D.L. Cahen, G.M. Fuhler, M. Wuhrer, B.A. Bonsing, R.A.E.M. Tollenaar, F.P. Vleggaar, H.F.A. Vasen, M.E. van Leerdam, M.J. Bruno, W.E. Mesker. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individualsPancreatology 2022; 22(4): 497 doi: 10.1016/j.pan.2022.03.021
39
Isaura S. Ibrahim, Hans F. A. Vasen, Martin N. J. M. Wasser, Shirin Feshtali, Bert A. Bonsing, Hans Morreau, Akin Inderson, Wouter H. de Vos tot Nederveen Cappel, Wilbert B. van den Hout. Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohortUnited European Gastroenterology Journal 2023; 11(2): 163 doi: 10.1002/ueg2.12360
40
Elena M. Stoffel, Shannon E. McKernin, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion SummaryJournal of Oncology Practice 2019; 15(2): 108 doi: 10.1200/JOP.18.00629
41
Ankit Chhoda, Ziga Vodusek, Kapil Wattamwar, Eric Mukherjee, Craig Gunderson, Alyssa Grimshaw, Anup Sharma, Nita Ahuja, Fay Kastrinos, James J. Farrell. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-AnalysisGastroenterology 2022; 162(3): 786 doi: 10.1053/j.gastro.2021.11.021
42
Juan Pablo Hinestrosa, Rosalie C. Sears, Harmeet Dhani, Jean M. Lewis, Gregor Schroeder, Heath I. Balcer, Dove Keith, Brett C. Sheppard, Razelle Kurzrock, Paul R. Billings. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinomaCommunications Medicine 2023; 3(1) doi: 10.1038/s43856-023-00351-4
43
Griffin McNamara, Karla Ali, Shraddha Vyas, Tri Huynh, Monica Nyland, Deanna Almanza, Christine Laronga, Jason Klapman, Jennifer Permuth. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer CenterGastrointestinal Disorders 2018; 1(1): 106 doi: 10.3390/gidisord1010008
44
Katherina P. Farr, Daniel Moses, Koroush S. Haghighi, Phoebe A. Phillips, Claudia M. Hillenbrand, Boon H. Chua. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research OpportunitiesCancers 2022; 14(10): 2539 doi: 10.3390/cancers14102539
45
Juan E. Corral, Karl F. Mareth, Douglas L. Riegert-Johnson, Ananya Das, Michael B. Wallace. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort StudiesClinical Gastroenterology and Hepatology 2019; 17(1): 41 doi: 10.1016/j.cgh.2018.04.065
46
Akiko Kowada. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in JapanPancreas 2020; 49(8): 1052 doi: 10.1097/MPA.0000000000001614
47
M.-P. Vullierme, M. Lagadec. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?Diagnostic and Interventional Imaging 2016; 97(12): 1233 doi: 10.1016/j.diii.2016.08.018
48
Uwe Pelzer. Pankreaskarzinom – Therapiestandards und spezielle Situationenbest practice onkologie 2018; 13(5): 238 doi: 10.1007/s11654-018-0098-2
49
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care2020; : 1809 doi: 10.1007/978-3-319-74588-6_180
50
Jonathan Kandiah, Tammy Lo, Dugho Jin, Landon Melchior, Thorsten L. Krebs, Naveen Anand, Susan Ingram, Pramila Krumholtz, Deep Pandya, Antolin Trinidad, Xiang (Eric) Dong, Ramanathan Seshadri, James Bauman, Ronald Lee, Richard C. Frank. A Community-Based Pancreatic Cancer Screening Study in High-Risk Individuals: Preliminary Efficacy and Safety ResultsClinical and Translational Gastroenterology 2022; 13(8): e00516 doi: 10.14309/ctg.0000000000000516
51
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomesWorld Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
52
Hiroki Sato, Andrew Scott Liss, Yusuke Mizukami. Large-duct pattern invasive adenocarcinoma of the pancreas–a variant mimicking pancreatic cystic neoplasms: A minireviewWorld Journal of Gastroenterology 2021; 27(23): 3262-3278 doi: 10.3748/wjg.v27.i23.3262
53
Salvatore Paiella, Erica Secchettin, Gabriella Lionetto, Livia Archibugi, Danila Azzolina, Fabio Casciani, Diane M. Simeone, Kasper A. Overbeek, Michael Goggins, James Farrell, Ruggero Ponz de Leon Pisani, Maddalena Tridenti, Maria Assunta Corciulo, Giuseppe Malleo, Paolo Giorgio Arcidiacono, Massimo Falconi, Dario Gregori, Claudio Bassi, Roberto Salvia, Gabriele Capurso. Surveillance of Individuals at High Risk of Developing Pancreatic CancerAnnals of Surgery 2024; 279(1): 37 doi: 10.1097/SLA.0000000000006094
54
Kari G. Rabe, Maria A. Stevens, Amanda Toledo Hernández, Shruti Chandra, Joleen M. Hubbard, Jennifer L. Kemppainen, Shounak Majumder, Gloria M. Petersen. Pancreatic cancer risk to siblings of probands in bilineal cancer settingsGenetics in Medicine 2022; 24(5): 1008 doi: 10.1016/j.gim.2022.01.016
55
Lauren Fried, Andrea Tan, Shirin Bajaj, Tracey N. Liebman, David Polsky, Jennifer A. Stein. Technological advances for the detection of melanomaJournal of the American Academy of Dermatology 2020; 83(4): 996 doi: 10.1016/j.jaad.2020.03.122
56
Tian-Bao Yan, Jia-Qi Huang, Shi-Yun Huang, Bhavesh K. Ahir, Long-Man Li, Zeng-Nan Mo, Jian-Hong Zhong. Advances in the Detection of Pancreatic Cancer Through Liquid BiopsyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.801173
57
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic CancerInternational Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
58
Natalia Khalaf, Basim Ali. New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of ScreeningClinical Gastroenterology and Hepatology 2022; 20(9): 1927 doi: 10.1016/j.cgh.2022.02.015
59
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital centerRevista de Gastroenterología de México (English Edition) 2021; 86(2): 118 doi: 10.1016/j.rgmxen.2020.04.005
60
Kjetil Søreide. Textbook of Pancreatic Cancer2021; : 339 doi: 10.1007/978-3-030-53786-9_23
61
Louis de Mestier, Marie Muller, Jérôme Cros, Marie-Pierre Vullierme, Dewi Vernerey, Frédérique Maire, Safi Dokmak, Vinciane Rebours, Alain Sauvanet, Philippe Lévy, Pascal Hammel. Appropriateness of pancreatic resection in high‐risk individuals for familial pancreatic ductal adenocarcinoma: a patient‐level meta‐analysis and proposition of the Beaujon scoreUnited European Gastroenterology Journal 2019; 7(3): 358 doi: 10.1177/2050640618824910